Alantos Pharmaceuticals

Dynamic international biopharmaceutical company focused on developing small molecule pharmaceuticals.

Launch date

1980

Market cap

Enterprise valuation

€273m (Public information from Jun 2007)

Thousand Oaks California (HQ)

Date	Investors	Amount	Round
-	Lightstone Ventures International Biotechnology Trust InterWest Partners Asset Management Ventures Domain Associates Ysios Capital Puget Sound Venture Club Oxford Bioscience Partners ABN AMRO Bank N.V. Ventech SV Health Investors	N/A	-
Feb 2003	Earlybird Venture Capital	N/A	Debt
Jul 2003	N/A	$27.7m	Series B
Mar 2005	N/A	$20.0m	Series B
Jun 2007	Amgen	$300m Valuation: $300m	Acquisition
Total Funding		€43.4m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Alantos Pharmaceuticals